| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 04/18/2001 | CN1064544C Chinese medicine powder for treating hepatic disease |
| 04/18/2001 | CN1064542C Traditional Chinese medicine for treatment of chronic rheumatic heart disease |
| 04/18/2001 | CN1064540C Medicine for burn and scald and preparing process |
| 04/18/2001 | CN1064536C Medicine for curing IV phase carcinoma of stomach |
| 04/18/2001 | CN1064535C Medicinal powder for treatment for chronic ulcerative colitis |
| 04/18/2001 | CN1064532C Pill for pelvic inflammation and cervical erosion |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218181 Retroviral packaging cell line |
| 04/17/2001 | US6217913 Cosmetic compositions with gorgonian extract |
| 04/17/2001 | US6217880 Medicament for treating recurrent ulcer of mouth and behcet's syndrome |
| 04/17/2001 | US6217865 Method of antibody blending for increased efficacy |
| 04/17/2001 | US6217860 Supplying adenoviral vector into tumor |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/12/2001 | WO2001025466A1 Producer cell for the production of retroviral vectors |
| 04/12/2001 | WO2001025465A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | WO2001025464A1 Materials and methods for simplified aav production |
| 04/12/2001 | WO2001025463A1 Recombinant adenoviruses preparation and adenovirus banks |
| 04/12/2001 | WO2001025462A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | WO2001025450A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | WO2001025442A1 Dna polymerase lambda and uses thereof |
| 04/12/2001 | WO2001025441A2 Tumour-specific vector for gene therapy |
| 04/12/2001 | WO2001025434A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | WO2001025422A2 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | WO2001025414A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | WO2001025405A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | WO2001025403A2 Bio-artificial substrate for the production of animal and, in particular, human tissues and organs |
| 04/12/2001 | WO2001025402A1 Isolation of precursor cells and their use for tissue repair |
| 04/12/2001 | WO2001025398A2 Process for inducing functional tolerance to gene transfer products |
| 04/12/2001 | WO2001025397A2 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | WO2001025321A1 3d matrix for producing cell transplants |
| 04/12/2001 | WO2001025271A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001024842A2 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | WO2001024824A1 Rhodamine derivatives for photodynamic diagnosis and treatment |
| 04/12/2001 | WO2001024818A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024813A1 Use of tgf beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
| 04/12/2001 | WO2001024812A1 USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA |
| 04/12/2001 | WO2001024804A2 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024637A1 Methods for treating solid tumors with irradiation and bacteria |
| 04/12/2001 | WO2000077190A3 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 04/12/2001 | WO2000071157A3 New vaccine formulations - 1 |
| 04/12/2001 | WO2000064458A3 Method for inducing a donor tolerance in the human body |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | WO1996037601B1 Cell differentiation agents |
| 04/12/2001 | US20010000204 Providing an in-line filtration device including a tumor cell reduction filter positioned the inlet port and the outlet port of the housing which retains tumor cells while the stem cell product flow through and is recovered; transplantation |
| 04/12/2001 | CA2699662A1 Rhodamine derivatives for photodynamic diagnosis, prevention and treatment of immunologic disorders |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2388229A1 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific t cell responses |
| 04/12/2001 | CA2386722A1 Materials and methods for simplified aav production |
| 04/12/2001 | CA2386546A1 Adeno-associated viruses and uses thereof |
| 04/12/2001 | CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy |
| 04/12/2001 | CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules |
| 04/12/2001 | CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method |
| 04/12/2001 | CA2385823A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385696A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | CA2385220A1 Antisense compositions and cancer-treatment methods |
| 04/12/2001 | CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 04/12/2001 | CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 04/12/2001 | CA2379971A1 Hybrid matrices and hybrid matrix mixtures |
| 04/11/2001 | EP1090642A2 Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 04/11/2001 | EP1090136A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090104A1 Methods of expanding and selecting disease associated t-cells |
| 04/11/2001 | EP1089767A1 Method of inactivating viruses |
| 04/11/2001 | EP1089745A1 Oregano for the treatment of internal parasites and protozoa |
| 04/11/2001 | EP0779929B1 Non self-inactivating, expression targeted retroviral vectors |
| 04/11/2001 | CN1291235A Vaccines immunotherapeutics and method for using the same |
| 04/11/2001 | CN1291231A Human telomerase catalytic subunit |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 04/11/2001 | CN1290553A Capsule for tonifying kidney |
| 04/11/2001 | CN1290549A Chinese medicine preparation for hair growth |
| 04/11/2001 | CN1290548A Chinese medicine preparation for rheumatic and rheumatoid diseases |
| 04/11/2001 | CN1290547A Medicine powder for curing angitis and its preparing method |
| 04/11/2001 | CN1290545A Composite trichogen |
| 04/11/2001 | CN1290544A Combined medicine for curing alopecia areata |
| 04/11/2001 | CN1290541A Nose drops for rhinitis |
| 04/11/2001 | CN1290532A Method for preparing Chinese medicine for curing apoplexy and hemiparalysis |
| 04/11/2001 | CN1290531A Method for preparing Chinese medicine for curing epilepsy |
| 04/11/2001 | CN1064400C Health wine with active components of scorpion and ant and its preparing process |
| 04/11/2001 | CN1064396C Extraction of yolk oil |
| 04/11/2001 | CN1064261C Ginseng royal jelly without delaminating deposition and its preparing method |
| 04/11/2001 | CN1064259C Medicine for curing dermatosis |
| 04/11/2001 | CN1064252C Hypoglycemic high calcium granule |
| 04/11/2001 | CN1064246C Fracture setting capsule for promoting blood-circulation and causing muscles and joints to relax |
| 04/11/2001 | CN1064242C Snake poison substitute medicine for give-up drug-taking and pain-killing, and curing senile dementia |
| 04/11/2001 | CN1064241C Snake poison anti-cancer medicine and its prepn. |
| 04/11/2001 | CN1064240C Analgesic injection and its preparing method |
| 04/11/2001 | CN1064239C High calcium matter for child and its prepn. |
| 04/10/2001 | US6215206 Rotary-linear actuator |
| 04/10/2001 | US6215041 Introducing non-human mammalian donor cell nucleus into no-human mammalian enucleated oocyte of same species, and implantation into uterus of surrogate mother for development |
| 04/10/2001 | US6214614 Cell cycle regulated repressor and DNA element |
| 04/10/2001 | US6214579 Flea leucine aminopeptidase nucleic acid molecules and uses thereof |
| 04/10/2001 | US6214369 Mesenchymal stem cells for cartilage repair |
| 04/10/2001 | US6214357 Treatment of diabetes |
| 04/10/2001 | US6214354 Immunizing a person older than fifty who has had varicella or who has had a live varicella vaccine with immunologically effective amount of attenuated varicella zoster virus oka strain, where amount is at least 1,000 plaque forming units |
| 04/10/2001 | US6214338 Comprising platelets and platelet releasate, from 5 to 400 mg/ml of fibrinogen, and a physiologically acceptable carrier comprising water and physiologically acceptable inorganic and organic ions at a physiologically acceptable concentration |